Next generation gold drugs and probes: chemistry and biomedical applications

RT Mertens, S Gukathasan, AS Arojojoye… - Chemical …, 2023 - ACS Publications
The gold drugs, gold sodium thiomalate (Myocrisin), aurothioglucose (Solganal), and the
orally administered auranofin (Ridaura), are utilized in modern medicine for the treatment of …

Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria

RV Sionov, D Steinberg - Microorganisms, 2022 - mdpi.com
Chronic and recurrent bacterial infections are frequently associated with the formation of
biofilms on biotic or abiotic materials that are composed of mono-or multi-species cultures of …

An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms

MK Suresh, R Biswas, L Biswas - International Journal of Medical …, 2019 - Elsevier
Staphylococcus aureus (S. aureus) readily forms biofilms on prosthetic devices such as the
pacemakers, heart valves, orthopaedic implants, and indwelling catheters. Its biofilms are …

Molecular mechanisms and clinical implications of the gold drug auranofin

S Shen, J Shen, Z Luo, F Wang, J Min - Coordination Chemistry Reviews, 2023 - Elsevier
Auranofin (AUR) is an orally available lipophilic gold-based anti-inflammatory compound
used for the treatment of rheumatoid arthritis (RA). Recent evidence indicates that AUR may …

Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics

Y Liu, Y Lu, Z Xu, X Ma, X Chen, W Liu - Drug Discovery Today, 2022 - Elsevier
Multidrug resistance (MDR) is a significant issue associated with the clinical application of
antibiotics. It is also challenging to discover and develop new antibiotics with novel …

Niclosamide—A promising treatment for COVID‐19

S Singh, A Weiss, J Goodman, M Fisk… - British journal of …, 2022 - Wiley Online Library
Vaccines have reduced the transmission and severity of COVID‐19, but there remains a
paucity of efficacious treatment for drug‐resistant strains and more susceptible individuals …

Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and …

AD Brunaugh, H Seo, Z Warnken, L Ding, SH Seo… - PloS one, 2021 - journals.plos.org
Niclosamide (NIC) has demonstrated promising in vitro antiviral efficacy against SARS-CoV-
2, the causative agent of the COVID-19 pandemic. Though NIC is already FDA-approved …

Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans

R Vazquez-Munoz, MJ Arellano-Jimenez… - BMC biomedical …, 2020 - Springer
Background Bismuth compounds are known for their activity against multiple
microorganisms; yet, the antibiotic properties of bismuth nanoparticles (BiNPs) remain …

[HTML][HTML] Drug repurposing to fight colistin and carbapenem-resistant bacteria

L Peyclit, SA Baron, JM Rolain - Frontiers in Cellular and Infection …, 2019 - frontiersin.org
The emergence of new resistance mechanisms, the failure of classical antibiotics in clinic,
the decrease in the development of antibiotics in the industry are all challenges that lead us …

[HTML][HTML] Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria

LO Felix, E Mylonakis, BB Fuchs - Frontiers in Microbiology, 2021 - frontiersin.org
There is a drought of new antibacterial compounds that exploit novel targets. Thioredoxin
reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has …